VOLUME 3, ISSUE 2, 2022 (JULY – DECEMBER)

Contents

Full issue

Editorial

Hepatobiliary disease in the COVID-19 era

Juan Carlos Restrepo-Gutiérrez

129-130

Review articles

Cardiomyopathy in patients with liver cirrhosis: review article

Esteban González-Domínguez, Diego Córdova, Paula Abad, Eduardo González, Camila González, Juan José Cordero

131-142

Hepatobiliary disease associated with COVID-19

Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya

143-154

Conventional and emerging therapies in primary biliary cholangitis

Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez

155-175

Hyperbilirubinemia: pathologist's view

Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio

176-190

Original articles

Histological liver changes caused by chronic intake of monosodium glutamate

Ana Patricia Fabro, María del Carmen Contini, Noelia Villafañe, Adriana Benmelej

191-202

Primary biliary cholangitis: characterization of a retrospective cohort

Edgar Fernando Ayala-Sierra, Octavio G. Muñoz-Maya, Felipe Guerrero-Pérez, Manuela Cardona-Jaramillo

203-217

Case reports

Hepatic hydrothorax as a rare complication of cirrhosis. A therapeutic challenge in advanced cirrhosis

Melissa Lara-Viáfara, Mauricio Salazar-Moreno, Juliana Suárez-Correa, Oscar Reyna-Carrasco

218-224

Sclerosing cholangitis associated with severe infection by SARS-CoV-2

Natalia Torres-Vellojín, Juan Camilo Díaz-Duque, Luz Adriana Gómez-Ramírez, Octavio G. Muñoz-Maya

225-232

Esta revista está bajo licencia internacional

Creative Commons Reconocimiento
NoComercial-SinObrasDerivadas 4.0.